FOLH1 and metastatic malignant neoplasm in the lymph nodes: PSMA-targeted radiolabeled and fluorescent probes are being tested for identifying lymph node metastases intraoperatively during PLND, for confirming appropriate surgical margins, and for correlation with pathological assessment (62–65).